Andrykowski, M.A., Schmidt, J.E., Salsman, J.M., et al. (2005). Use of a case definition approach to identify cancer-related fatigue in women undergoing adjuvant therapy for breast cancer. Journal of Clinical Oncology, 23(27), 6613–6622.
Armes, J., Chalder, T., Addington-Hall, J., et al. (2007). A randomized controlled trial to evaluate the effectiveness of a brief, behaviorally oriented intervention for cancer-related fatigue. Cancer, 110(6), 1385–1395.
Bruera, E., Kuehn, N., Miller, M.J., et al. (1991). The Edmonton Symptom Assessment System (ESAS): A simple method for the assessment of palliative care patients. Journal of Palliative Care, 7(2), 6–9.
Bruera, E., Driver, L., Barnes, E.A., et al. (2003). Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: A preliminary report. Journal of Clinical Oncology, 21(23), 4439–4443.
Bruera, E., Yennurajalingam, S., Palmer, J.L., et al. (2013). Methylphenidate and/or a nursing telephone intervention for fatigue in patients with advanced cancer: A randomized, placebo-controlled, phase II trial. Journal of Clinical Oncology, 31(19), 2421–2427.
Campos, M.P., Hassan, B.J., Riechelmann, R., et al. (2011). Cancer-related fatigue: A review. Revista da Associação Médica Brasileira, 57(2), 211–219.
Cella, D., Davis, K., Breitbart, W., et al. (2001). Cancer-related fatigue: Prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. Journal of Clinical Oncology, 19(14), 3385–3391.
Chang, V.T., Hwang, S.S. & Feuerman, M. (2000). Validation of the Edmonton Symptom Assessment Scale. Cancer, 88(9), 2164–2171.
Debb, S.M., Arnold, B., Perez, B., et al. (2011). Validation of the FACT–Gastric cancer quality of life questionnaire for use in Spanish-speaking countries. Psycho-Oncology, 20(1), 19–27.
Esquerdo, G., Llorca, C., Cervera, J.M., et al. (2011). Effectiveness of darbepoetin alfa in a cohort of oncology patients with chemotherapy-induced anaemia: Relationship between variation in three fatigue-specific quality-of-life questionnaire scores and change in haemoglobin level. Clinical & Translational Oncology, 13(5), 341–347.
FACIT.org (2010). Functional Assessment of Chronic Illness Therapy. Available at www.facit.org.
Fernandes, R., Stone, P., Andrews, P., et al. (2006). Comparison between fatigue, sleep disturbance, and circadian rhythm in cancer inpatients and healthy volunteers: Evaluation of diagnostic criteria for cancer-related fatigue. Journal of Pain and Symptom Management, 32(3), 245–254.
Groenvold, M., Petersen, M.A., Aaronson, N.K., et al. (2006). The development of the EORTC QLQ–C15–PAL: A shortened questionnaire for cancer patients in palliative care. European Journal of Cancer, 42(1), 55–64.
Johnson, R.L., Block, I., Gold, M.A., et al. (2010). Effect of methylphenidate on fatigue in women with recurrent gynecologic cancer. Psycho-Oncology, 19(9), 955–958.
Kurihara, M., Shimizu, H., Tsuboi, K., et al. (1999). Development of quality of life questionnaire in Japan: Quality of life assessment of cancer patients receiving chemotherapy. Psycho-Oncology, 8(4), 355–363.
Levy, M.H., Adolph, M.D., Back, A., et al. (2012). Palliative care. Journal of the Nationall Comprehensive Cancer Network, 10(10), 1284–1309.
Mendoza, T.R., Wang, X.S., Cleeland, C.S., et al. (1999). The rapid assessment of fatigue severity in cancer patients: Use of the Brief Fatigue Inventory. Cancer, 85(5), 1186–1196.
Minton, O., Richardson, A., Sharpe, M., et al. (2010). Drug therapy for the management of cancer-related fatigue. The Cochrane Database of Systematic Reviews, (7), CD006704.
Revicki, D.A., Stull, D., Vernon, M., et al. (2012). Assessing the effect of darbepoetin alfa on patient-reported fatigue in chemotherapy-induced anemia in four randomized, placebo-controlled clinical trials. Quality of Life Research, 21(2), 311–321.
Sarhill, N., Walsh, D., Nelson, K.A., et al. (2001). Methylphenidate for fatigue in advanced cancer: A prospective open-label pilot study. The American Journal of Hospice & Palliative Care, 18(3), 187–192.
Schneider, C.M., Hsieh, C.C., Sprod, L.K., et al. (2007). Effects of supervised exercise training on cardiopulmonary function and fatigue in breast cancer survivors during and after treatment. Cancer, 110(4), 918–925.
Wewers, M.E. & Lowe, N.K. (1990). A critical review of visual analogue scales in the measurement of clinical phenomena. Research in Nursing & Health, 13(4), 227–236.
Yeh, E.T., Lau, S.C., Su, W.J., et al. (2011). An examination of cancer-related fatigue through proposed diagnostic criteria in a sample of cancer patients in Taiwan. BMC Cancer, 11, 387.
Yennurajalingam, S., Frisbee-Hume, S., Palmer, J.L., et al. (2013). Reduction of cancer-related fatigue with dexamethasone: A double-blind, randomized, placebo-controlled trial in patients with advanced cancer. Journal of Clinical Oncology, 31(25), 3076–3082.